Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity.

Halseth A, Shan K, Walsh B, Gilder K, Fujioka K

Understanding the Capacity for Exercise in Post-Bariatric Patients.

Coleman KJ, Caparosa SL, Nichols JF, Fujioka K, Koebnick C, McCloskey KN, Xiang AH, Ngor EW, Levy SS

Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers.

Fujioka K, O'Neil PM, Davies M, Greenway F, C W Lau D, Claudius B, Skjøth TV, Bjørn Jensen C, P H Wilding J

Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes.

O'Neil PM, Miller-Kovach K, Tuerk PW, Becker LE, Wadden TA, Fujioka K, Hollander PL, Kushner RF, Timothy Garvey W, Rubino DM, Malcolm RJ, Weiss D, Raum WJ, Salyer JL, Hermayer KL, Rost SL, Veliko JL, Sora ND

Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight loss.

Handelsman Y, Fain R, Wang Z, Li X, Fujioka K, Shanahan W

Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

Hwang SS, Takata MC, Fujioka K, Fuller W

Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management.

Fujioka K, Braverman-Panza J

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.

Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines

Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case report.

Fujioka K, Nishimura T, Seki M, Kinoshita M, Mishima N, Irimajiri S, Yamato M

Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Schwartz LK, O'Keefe SJ, Fujioka K, Gabe SM, Lamprecht G, Pape UF, Li B, Youssef NN, Jeppesen PB